• This trial is a prospective, multicenter, non-blinded, non-randomized study of the Relay PRO Thoracic Stent-Graft in subjects with Thoracic Aortic Aneurysms (TAAs) and Penetrating Atherosclerotic Ulcers (PAUs)
• The purpose of this study is to investigate the safety and effectiveness of the Relay PRO Thoracic Stent-Grafts in subjects with aneurysms and PAUs within the descending thoracic aorta.

Study Overview

• The ROADSTER 2 Study is an open label, single arm, multi-center post-approval Study for the treatment of patients at high risk for adverse events from carotid endarterectomy who require carotid revascularization and who are eligible for treatment with a combination of the ENROUTE Transcarotid Stent System and the ENROUTE Transcarotid NPS

The purpose of this study is to test an investigational device called the Echopulse for treatment of breast fibroadenomas in women. Fibroadenomas are benign (noncancerous) breast tumors. These lumps can occur alone, in groups, or as a complex of lumps together. Sometimes women feel these in the breast when doing regular self-breast exams, or they may be found during a routine mammogram. Some are small (less than an inch in size), and others are quite large (the size of a lemon or larger).Several symptoms could be associated to the presence of fibroadenoma.

This is a multi-center prospective, single-arm, non-randomized, open label study to assess feasibility of the Xeltis Bioabsorbable Pulmonary Valved Conduit in subjects requiring Right Ventricular Outflow Tract correction or reconstruction due to congenital heart malformations.

The objective of this trial is to assess the safety and effectiveness of the study device in subjects with degenerative mitral valve disease receiving a mitral valve repair without cardiopulmonary bypass (treatment group) when compared to subjects receiving mitral valve repair using standard surgical techniques with cardiopulmonary bypass (control group).

Gastroesophageal reflux disease (GERD) is a chronic digestive disease that affects nearly 65 million people in the United States.¹ It occurs when stomach acid or stomach contents flow back into your food pipe (esophagus). The backwash (reflux) irritates the lining of your esophagus and causes GERD.² Frequent and troublesome symptoms may include one or more of the following: heartburn, regurgitation, sleep disruption, vocal impairment, and respiratory complications.

This trial will be comparing the Eluvia stent with the Zilver PTX stent in patients with chronic, symptomatic atherosclerosis of the lower extremities. The primary objective of this trial is to evaluate the safety and effectiveness of the ELUVIA Drug-Eluting Vascular Stent System.

This study will compare the effectiveness of best available surgical treatment with best available endovascular treatment in adults with critical limb ischemia (CLI) who are eligible for both treatment options.

To determine the efficacy of early integrated palliative care on patient reported quality of life at 12 weeks using the FACT in patients with newly diagnosed incurable lung or non-colorectal gastrointestinal cancer

By studying healthy mastectomy specimens, we hope to delineate breast ductal anatomy  and gain a better understanding of ductal layout.